Effect of cyclodextrins on the solubility and antimycotic activity of sertaconazole: Experimental and computational studies

Journal of Pharmaceutical Sciences

Volumn 91, Issue 11, 2002, Pages 2408-2415

  Perdomo Lopez I ^a   Rodriguez Perez A I ^a   Yzquierdo Peiro J M ^a   White, A ^b   Estrada, E G ^a   Villa, T G ^a   Torres Labandeira, J J ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Antimycotic effect; Cyclodextrins; Molecular modeling; Sertaconazole nitrate; Solubility

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ALPHA CYCLODEXTRIN; BETA CYCLODEXTRIN; CYCLODEXTRIN DERIVATIVE; GAMMA CYCLODEXTRIN; HYDROXYPROPYL GAMMA CYCLODEXTRIN; SERTACONAZOLE; UNCLASSIFIED DRUG; WATER;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; COMPLEX FORMATION; COMPUTER ANALYSIS; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; DRUG STRUCTURE; FREEZE DRYING; INFRARED SPECTROSCOPY; INTESTINE FLUID; MOLECULAR MODEL; NONHUMAN; SIMULATION; STOMACH JUICE; VACUUM; X RAY POWDER DIFFRACTION;

EID: 0036828137     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10237     Document Type: Article

References (28)

1. Bouza E, Muñoz P. 1993. Comentarios a la literatura en enfermedades infecciosas. VIII. In: Micosis Sistémicas Oportunistas. Aportaciones Recientes. Madrid: Elba, pp 112-117.
2. Ortiz JA. 1992. Sertaconazole (FI-7045). A new antifungal agent. Introduction. Arzneimittelforschung 42:689-690.
3. Fromtling RA. 1987. Introduction: The need for antifungal agents. In: Fromtling RA, editor. International telesymposium on recent trends in the discovery, development and evaluation of antifungal agents. Barcelona: Prous, pp 1-3.
4. Carrillo-Muñeoz AJ, Tur-Tur C. 1997. Comparative study of antifungal activity of sertaconazole, terbinafrine, and bifonazole against clinical isolates of Candida spp., Cryptococcus neoformans and Dermatophytes. Chemotherapy 43:387-392.
5. Palacin C, Tarrago C, Ortiz JA. 2000. Sertaconazole: Pharmacology of a gynecological antifungal agent. Int J Gynaecol Obstet 71(Suppl 1):S37-S46.
6. Palacin C, Sacristán A, Ortiz JA. 1992. In vitro activity of sertaconazole. Arzneimittelforschung 42:699-704.
7. Drouhet E, Dupont B. 1992. In vitro antifungal activity of sertaconazole. Arzneimittelforschung 42:705-710.
8. Agut J, Moren M, Rego M, Sacristan A, Ortiz JA. 1992. Pharmacokinetic evaluation of labelled sertaconazole after dermal application. Arzneimittelforschung 42:748-751.
9. Agut J, Palacín C, Sacristan A, Ortiz JA. 1992. Inhibition of ergosterol synthesis by sertaconazole in Candida albicans. Arzneimittelforschung 42:718-720.
10. Agut J, Palacín C, Salgado J, Casas E, Sacristán A, Ortiz JA. 1992. Direct membrane-damaging effect of sertaconazole on Candida albicans as a mechanism of its fungicidal activity. Arzneimittelforschung 42:21-24.
11. Albet C, Fernández JM, Sacristán A, Ortiz JA. 1992. Physico-chemical properties, analytical determinations and stability of sertaconazole nitrate. Arzneimittelforschung 42:695-698.
12. Loftsson T, Brewster M. 1996. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci 85:1017-1025.
13. Higuchi T, Connors KA. 1965. Phase-solubility techniques. In: Reilly CN, editor. Advances in Analytical Chemistry and Instrumentation. Vol. 4. New York: Wiley-Interscience, pp 117-212.
14. Khan KA. 1975. The concept of dissolution efficiency. J Pharm Pharmacol 27:48-49.
15. Allinger NL. 1977. Conformational analysis. 130. MM2. A hydrocarbon force field utilizing V1 and V2 torsional terms. J Am Chem 99:8127-8134.
16. Hyperchem 3.0. for Windows, Hypercube, Inc., 1993.
17. Chang R. Chemistry. 4th Ed. New York: McGraw-Hill, pp 729-731.
18. Uekama K, Hirayama F. 1996. Improvement of drug properties by cyclodextrins. In: Wermuth CG, editor. The Practice of Medicinal Chemistry. London: Academic Press, pp 793-825.
19. Stzejtli J. 1994. Medicinal applications of cyclodextrins. Med Res Rev 14:353-386.
20. Trapani G, Latrofa A, Franco M, Pantaleo MR, Sanna E, Massa F, Tuveri F, Liso G. 2000. Complexation of Zolpiden with 2-hydroxypropyl-β-, methyl-β-, and 2-hydroxypropyl-γ-cyclodextrin. Effect on aqueous solubility, dissolution rate and ataxic activity in rat. J Pharm Sci 89:1443-1451.
21. Martin-Mazuelos E, Aller AI, Morilla D, Montero O. 1996. Antifungal activity of sertaconazole in vitro againtst clinical isolates of Candida spp. Chemotherapy 42:112-117.
22. Pedersen M, Edelsten M, Nielsen VF, Scarpellini A, Skytte S, Slot C. 1993. Formation and antimycotic effect of cyclodextrin inclusion complexes of econazole and miconazole. Int J Pharm 90:247-254.
23. Ahmed MO, El-Gibaly I, Ahmed SM. 1998. Effect of cyclodextrins on the physicochemical properties and antimycotic activity of clotrimazole. Int J Pharm 171:111-121.
24. Eftink MR, Andy ML, Bystrom K, Perlmutter HD, Kristol DS. 1989. Cyclodextrin inclusion complexes: Studies of the variation in the size of alicyclic guests. J Am Chem Soc 111:6665-6772.
25. Ross PD, Rekharsky MV. 1996. Thermodynamics of hydrogen bond and hydrophobic interaction in cyclodextrin complexes. Biophys J 71:2144-2154.
26. Wang R, Gao Y, Lai L. 2000. Calculating partition coefficient by atom-additive method. Perspect Drug Discov Des 19:47-66.
27. Piel G, Dive G, Evrard B, Van Hess T, Henry de Hassonville S, Delattre L. 2001. Molecular modeling study of β- and γ-cyclodextrin complexes with miconazole. Eur J Pharm Sci 13:271-279.
28. Estrada E, Perdomo-López I, Torres-Labandeira JJ. 2000. Molecular modeling (MM2 and PM3) and experimental (NMR and thermal analysis) studies on the inclusion complex of salbutamol and β-cyclodextrin. J Org Chem 65:8510-8517.